Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
61 /100
HIGH RISK
Score updated Aug 28, 2026

COEP — Coeptis Therapeutics Holdings Inc Dilution Risk Tracker

Track COEP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track COEP — Get alerts when the score changes →

As of August 28, 2026, Coeptis Therapeutics Holdings Inc (COEP) has a DilutionWatch DilutionScore of 61/100, rated HIGH dilution risk. Coeptis Therapeutics Holdings Inc has a market capitalization of $102.06M, 53.00M shares outstanding. Stored dilution-related fields include ATM program capacity of $20.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
10
📊 Float Risk
95
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 12%
💰 Capital Raise model 18%
• Active ATM program with $20M remaining capacity
📉 Score Deterioration model 10%
• Score in HIGH risk zone (61/100)
🔔 Track COEP — Get forecast alerts →

Market Data

Market Cap$102.06M
Shares Outstanding53.00M
Float5.25M
Cash$15.54M
Debt$150.0K
Short InterestN/A

Institutional Holdings

Institutional data not yet available.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-06-30
xbrl XBRL WARRANT 2025-12-31
8-K 8K EVENT 2026-05-01
4 INSIDER TRANSACTION 2026-04-30
4 INSIDER TRANSACTION 2026-04-30
Full SEC filing analysis available with free account

Recent News

No recent news

Factual COEP Dilution Snapshot

Coeptis Therapeutics Holdings Inc (COEP) has a DilutionScore of 61/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track COEP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking COEP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for COEP
COEP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.